{"id":"W2048623699","doi":"10.1186/1471-2407-9-433","title":"HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy","year":2009,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Eli Lilly Canada; Michael Smith Health Research BC; Sanofi; BC Cancer Agency; Eli Lilly and Company","keywords":"Trastuzumab; Medicine; Mucinous carcinoma; Oncology; Carboplatin; Mucinous Tumor; Surgical oncology; Ovarian cancer; Chemotherapy; Internal medicine; Targeted therapy; Paclitaxel; Immunohistochemistry; Cancer; Pathology; Adenocarcinoma; Breast cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003539169,0.0001674122,0.0002175399,0.0003931636,0.0001457887,0.0002083891,0.000159708,0.0001772682,0.0006116501],"category_scores_gemma":[0.001213982,0.0001108657,0.0001358721,0.0003171095,0.0002182425,0.0001508399,0.0001949672,0.0001595011,0.000110715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001720256,"about_ca_system_score_gemma":0.0001255701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005076941,"about_ca_topic_score_gemma":0.0007811189,"domain_scores_codex":[0.999835,0.00003154328,0.0000156144,0.00001866555,0.00005867063,0.00004053718],"domain_scores_gemma":[0.9995083,0.0001236695,0.0002555509,0.000033557,0.00003697535,0.00004197018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005056358,0.00004677226,0.8754801,0.00009097657,0.0000561031,0.006659871,0.0002047941,0.0003120203,0.07735056,0.00007157517,0.0002038987,0.03901779],"study_design_scores_gemma":[0.00003413129,0.0005308498,0.9112275,0.00002121454,0.0001088183,0.06113609,0.0002383486,0.0008073454,0.02354777,0.0001832941,0.002157908,0.000006734888],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989601,0.000564879,0.000166568,0.00002002284,8.282956e-7,0.000004655323,0.00001619963,0.000006564576,0.0002600403],"genre_scores_gemma":[0.9995139,0.0002447131,0.0001345721,0.000008393275,0.000004206717,0.000003112251,0.00003800389,0.00000119786,0.00005209662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006116501,"threshold_uncertainty_score":0.002046227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06060265793451496,"score_gpt":0.3509393049700187,"score_spread":0.2903366470355037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}